Disease/Infection News

RSS

WHO convenes experts for operational response to 2014 Ebola outbreak in West Africa

The emergence of an Ebola virus disease outbreak in West Africa in 2014 has become a challenge to the 3 countries involved, as the Governments of Guinea, Liberia and Sierra Leone work intensively with WHO and other partners to ramp up a series of measures to control the outbreak.

27 Jun 2014

University of Utah researcher to receive Nelson Trust Award for Retinitis Pigmentosa

Research to Prevent Blindness, a New York-based foundation, has announced that University of Utah researcher Wolfgang Baehr, Ph.D., will receive the Nelson Trust Award for Retinitis Pigmentosa-and an accompanying $100,000 to pursue new scientific leads to understand contributors to blindness.

27 Jun 2014

ASPIRE completes patient enrollment in Phase III trial of vaginal ring for HIV prevention

ASPIRE, one of two Phase III trials of a promising method for preventing HIV in women - a vaginal ring worn for a month at a time - has completed enrollment of participants, with 2,629 women from 15 clinical research sites in Malawi, South Africa, Uganda and Zimbabwe now taking part in the study.

27 Jun 2014

New article explores how specific types of interferons control RNA virus infection

Respiratory and intestinal infections caused by RNA viruses stimulate infected cells to produce interferons, which can act alone or in combination to block virus replication.

27 Jun 2014

Personalized antibiotic therapy can help fight antibiotic-resistant infections

The Centers for Disease Control and Prevention warned last fall that the U.S. faces "potentially catastrophic consequences" if it doesn't act quickly to combat the growing threat of antibiotic-resistant infections, which kill about 23,000 Americans a year.

27 Jun 2014

Interactions with other infections can trigger herpes virus to reactivate, shows research

The famous slogan is "A diamond is forever," but that phrase might be better suited to herpes: Unlike most viruses, which succumb to the immune system's attack, herpes remains in the body forever, lying in wait, sometimes reactivating years later.

27 Jun 2014

Current sequencing protocols overlook DNA crucial to bacterial virulence

Genomic sequencing is supposed to reveal the entire genetic makeup of an organism. For infectious disease specialists, the technology can be used to analyze a disease-causing bacterium to determine how much harm it is capable of causing and whether or not it will be resistant to antibiotics.

26 Jun 2014

Researchers compare genome sequences of malaria vectors to investigate insecticide resistance

Researchers from LSTM have exploited a natural experiment created by insecticidal pressure to determine how the most important malaria vectors - A. gambiae s.s. and A. coluzzii - respond rapidly to environmental change.

26 Jun 2014

USAMRIID scientists propose new standards to sequence viral genomes

Scientists at the U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID) have proposed a set of standards aimed at developing a common "language" among investigators working to sequence viral genomes and characterize viral stocks.

26 Jun 2014

Research: TB infection among people taking corticosteroid pills may be underestimated

Tuberculosis infection among people taking corticosteroid pills may be underestimated, new research suggests.

26 Jun 2014

Study questions whether health system, government policies can meet needs of people aging with HIV

As the first people with HIV grow old, a new study from St. Michael's Hospital questions whether the health care system and other government policies are prepared to meet their complex medical and social needs.

26 Jun 2014

New wound treatment with material leads to faster healing, prevents harmful bacteria from sticking

As many patients know, treating wounds has become far more sophisticated than sewing stitches and applying gauze, but dressings still have shortcomings.

26 Jun 2014

Advancements in HIV treatment help patients live longer

Huge advancements have taken place in HIV treatment and prevention over the past 10 years, but there is still no cure or vaccine. A new review shows that because of advancements in treatment, people with the virus are living longer.

25 Jun 2014

Henry Ford launches clinical trial for treatment of tinnitus caused by noise trauma

Henry Ford Health System has launched a clinical trial to investigate a new drug for the treatment of tinnitus, a chronic ringing of the head or ears that affects more than 600 million people worldwide.

25 Jun 2014

Frederic Bushman gets Pioneer Award from Human Gene Therapy

Frederic D. Bushman, PhD's (University of Pennsylvania Perelman School of Medicine) early pioneering work in understanding how HIV reproduces by inserting its genetic material into the DNA of a host cell led to key advances in the ability to move pieces of DNA and whole genes between cells.

25 Jun 2014

Wild fleas transmit Chagas' disease in some regions of Latin America

For 10 years, major fumigation campaigns in the villages have eliminated the fleas that transmit Chagas' disease in many Latin American countries.

25 Jun 2014

Study finds link between high CD4 cell counts and reduced ischemic stroke risk in people with HIV

A 15-year study found that HIV-positive individuals had a 40 percent increased risk of ischemic stroke, however stroke rates were nearly the same for HIV-positive individuals with high CD4 cell counts as for HIV-negative subjects.

24 Jun 2014

Scientists turn to old class of antibiotics to fight superbugs resistant to modern medicine

Scientists at the University at Buffalo are turning to an old class of antibiotics to fight new superbugs resistant to modern medicine.

24 Jun 2014

Antiviral therapy can reduce risk of liver cancer in patients with chronic hepatitis B infection

One of the most severe complications of hepatitis B is the development of liver cancer, which is responsible for approximately 745,000 deaths worldwide each year.

24 Jun 2014

Aradigm begins Pulmaquin Phase III study for treatment of non-CF BE

Aradigm Corporation ("Aradigm" or the "Company") today announced the dosing of the first patient in the ORBIT-4 (Once-daily Respiratory Bronchiectasis Inhalation Treatment) Phase III pivotal clinical trial of Aradigm's proprietary formulation of inhaled ciprofloxacin (Pulmaquin®) for the treatment of non-cystic fibrosis bronchiectasis (non-CF BE).

23 Jun 2014

Disease/Infection News

WHO convenes experts for operational response to 2014 Ebola outbreak in West Africa

University of Utah researcher to receive Nelson Trust Award for Retinitis Pigmentosa

ASPIRE completes patient enrollment in Phase III trial of vaginal ring for HIV prevention

New article explores how specific types of interferons control RNA virus infection

Personalized antibiotic therapy can help fight antibiotic-resistant infections

Interactions with other infections can trigger herpes virus to reactivate, shows research

Current sequencing protocols overlook DNA crucial to bacterial virulence

Researchers compare genome sequences of malaria vectors to investigate insecticide resistance

USAMRIID scientists propose new standards to sequence viral genomes

Research: TB infection among people taking corticosteroid pills may be underestimated

Study questions whether health system, government policies can meet needs of people aging with HIV

New wound treatment with material leads to faster healing, prevents harmful bacteria from sticking

Advancements in HIV treatment help patients live longer

Henry Ford launches clinical trial for treatment of tinnitus caused by noise trauma

Frederic Bushman gets Pioneer Award from Human Gene Therapy

Wild fleas transmit Chagas' disease in some regions of Latin America

Study finds link between high CD4 cell counts and reduced ischemic stroke risk in people with HIV

Scientists turn to old class of antibiotics to fight superbugs resistant to modern medicine

Antiviral therapy can reduce risk of liver cancer in patients with chronic hepatitis B infection

Aradigm begins Pulmaquin Phase III study for treatment of non-CF BE

The Proteoform Puzzle: Unlocking the Next Frontier

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Latest News